Many of my patients notice a dramatic drop in food cravingsespecially for sugar and carbs
" We're going to have a pretty robust demand and we just wanted to make sure we had a partner that they could fulfill those prescriptions once they came in." Andrew Dudum, CEO and co-founder of Hims & Hers, said the company leveraged its "size and scale to secure access to one of the highest-quality supplies of compounded GLP-1 injections available today." "Were passing that access and value along to our customers, who deserve a high standard of clinical safety and validation to meet their goals, and we're doing it in a safe, affordable way that others cant deliver," Dudum said
In line with previous reports 43,44,45 our data support the notion that non -cell actions of GLP-1 agonists can improve glycaemic control
"With tools like our new AI-driven Dynamic Calorie Goals and the Welli Meal Planner, we're making it easier for GLP-1 users to stay on track and see real results." Noom is making meal planning more manageable and personalized with the Welli Meal Planner
In a 64-week trial enrolling 307 overweight adults, oral semaglutide 25 mg once daily caused an average weight loss of 13.6% compared to 2.2% with placebo
